HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis.

Abstract
Toll-like receptors (TLRs) initiate an innate immune response. TLR3 on dendritic cells recognize double-stranded (ds) RNA and then signal increases in cytokines and recognition molecules important for immune cell interactions. In this report, we demonstrate TLR3 mRNA and protein are expressed on Fisher rat thyroid cell line-5 (FRTL-5) thyroid cells and are functional because incubating cells with polyinosine-polycytidylic acid causes 1) transcriptional activation of both the nuclear factor kappaB (NF-kappaB)/Elk1 and interferon (IFN) regulatory factor-3/IFN-beta signal paths, 2) posttranscriptional activation of NF-kappaB and ERK1/2, and 3) increased IFN-beta mRNA. TLR3 can be overexpressed, along with dsRNA-dependent protein kinase, major histocompatibility complex-I or II, and IFN regulatory factor-1, by transfecting dsRNA into the cells, infection with Influenza A virus, or incubation with IFN-beta, but not by incubation with dsRNA or IFNgamma, or by dsDNA transfection. A methimazole (MMI) derivative, phenylmethimazole, to a significantly greater degree than MMI, prevents overexpression by inhibiting increased transcriptional activation of IRF-3 and of IFN-stimulated response elements, phosphorylation of signal transducers and activation of transcription (STAT-1), but not NF-kappaB activation. TLR3 can be functionally overexpressed in cultured human thyrocytes by dsRNA transfection or IFN-beta treatment. Immunohistochemical studies show that TLR3 protein is overexpressed in human thyrocytes surrounded by immune cells in 100% of patients with Hashimoto's thyroiditis examined, but not in normal or Graves' thyrocytes. We conclude that functional TLR3 are present on thyrocytes; TLR3 downstream signals can be overexpressed by pathogen-related stimuli; overexpression can be reversed by phenylmethimazole to a significantly greater extent than MMI by inhibiting only the IFN regulatory factor-3/IFN-beta/signal transducers and activation of transcription arm of the TLR3 signal system; and TLR3 overexpression can induce an innate immune response in thyrocytes, which may be important in the pathogenesis of Hashimoto's thyroiditis and in the immune cell infiltrates.
AuthorsNorikazu Harii, Christopher J Lewis, Vasilly Vasko, Kelly McCall, Uruguaysito Benavides-Peralta, Xiaolu Sun, Matthew D Ringel, Motoyasu Saji, Cesidio Giuliani, Giorgio Napolitano, Douglas J Goetz, Leonard D Kohn
JournalMolecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 19 Issue 5 Pg. 1231-50 (May 2005) ISSN: 0888-8809 [Print] United States
PMID15661832 (Publication Type: Journal Article)
Chemical References
  • Chemokines, CC
  • Membrane Glycoproteins
  • RNA, Double-Stranded
  • RNA, Messenger
  • Receptors, Cell Surface
  • TLR3 protein, human
  • Thiones
  • Toll-Like Receptor 3
  • Toll-Like Receptors
  • phenyl methimazole
  • Ccl6 protein, mouse
  • Methimazole
  • Interferon-beta
Topics
  • Animals
  • Chemokines, CC (metabolism)
  • Gene Expression (drug effects)
  • Humans
  • Influenza A virus (metabolism)
  • Interferon-beta (metabolism)
  • Membrane Glycoproteins (genetics, metabolism)
  • Methimazole (analogs & derivatives, pharmacology)
  • Mice
  • RNA, Double-Stranded
  • RNA, Messenger (metabolism)
  • Rats
  • Receptors, Cell Surface (genetics, metabolism)
  • Signal Transduction (physiology)
  • Thiones (pharmacology)
  • Thyroid Gland (drug effects, metabolism, pathology)
  • Thyroiditis, Autoimmune (metabolism, pathology)
  • Toll-Like Receptor 3
  • Toll-Like Receptors
  • Transfection
  • Virus Diseases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: